Media Inquiries
iCAD, Inc.
603.882.5200
pr@icadmed.com
From the Newsroom
August 16, 2023
Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment
August 14, 2023
iCAD Reports Financial Results for Second Quarter Ended June 30, 2023
July 31, 2023
iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023
July 18, 2023
iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation’s Largest Radiology Practice
Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment
iCAD Reports Financial Results for Second Quarter Ended June 30, 2023
iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023
iCAD Signs Strategic Commercial Agreement with Radiology Partners, the Nation’s Largest Radiology Practice
» View all news »
What's Trending
Explore the Latest Information from iCAD
Press ReleasesLearn More>EventsLearn More>iNFORMED BlogLearn More>Media CoverageLearn More>InvestorsLearn More>Clinical Case StudiesLearn More>Customer TestimonialsLearn More>
Stay Connected
Follow us on social media to stay connected and informed on all the latest iCAD news, events and product announcements.
CONTACT US
Products
ProFound AI for DBT
ProFound AI Risk
PowerLook Density Assessment
ProFound AI Solutions - EU
ProFound AI Solutions - FR
SecondLook for 2D Mammography
VeraLook Colon Polyp Detection
Resources
ProFound Institute
Educational Webinars
Customer Case Studies
Customer Testimonials
Patient Resources
Compliance
Training & Support
Partner Portal
EU Customer Portal
Precise and Powerful Healthcare Solutions
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.